Patents Examined by Hasan S. Ahmed
  • Patent number: 11691025
    Abstract: A method for reversing or mitigating skin aging comprising topically applying a composition which comprises at least one oxidant, and at least one fluorescent dye capable of activating the oxidant and illuminating said composition for a time sufficient to activate the at least one oxidant.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: July 4, 2023
    Inventors: Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
  • Patent number: 11654298
    Abstract: The present disclosure provides a method for treating clinical or pre-clinical skin damage in a skin field of a subject, wherein the skin field has been allocated a skin cancerization field index (SCR) score of at least 1 as determined by a process comprising the steps of: (i) assessing the number of keratoses in the skin field; (ii) assessing the thickness of the thickest keratosis in the skin field; and (iii) assessing the proportion of the field affected by clinical or subclinical skin damage. Based on the assessments made in (i), (ii) and (iii) the subject is optionally treated by at least one of (a) freezing one or more lesions, (b) shaving, curetting or surgically removing one or more lesions, (c) applying a topical treatment for actinic keratosis, basal cell carcinoma or squamous cell carcinoma, and (d) radiation therapy.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: May 23, 2023
    Assignee: GenesisCare Ventures Pty Ltd
    Inventors: Christopher Baker, Judith Mary Cole, Robert Sinclair, Warren Weightman, Stephen Shumack, Lynda Spelman, Peter Foley
  • Patent number: 11571370
    Abstract: A wipe has a substrate, a treatment solution impregnated into the substrate, the treatment solution including an antifungal agent, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution is essentially free of alcohol. A treatment solution, has an antifungal agent, an antifungal agent solvent, and a carrier fluid, wherein the treatment solution has an alcohol content of 6 wt % or below of the total solution.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: February 7, 2023
    Assignee: PELLI SKIN CO., LLC
    Inventors: Jesse Villarreal, Jr., Carolyn Shawn Murphy
  • Patent number: 11565018
    Abstract: A method of promoting hemostasis in the mouth or oral cavity utilizes a non-absorbent, low surface energy and highly conformable non-disruptive hemostasis material. Traditional wound packing material is highly absorbent and has large open surfaces that allow clot forming materials, such as the platelet plug to adhere to the packing material and whereupon removal, the clot is disrupted. A non-disruptive highly conformable hemostasis material does not have large open pores and therefore does not adhere to forming clots. A non-disruptive hemostasis material may consist of expanded polytetrafluoroethylene that has a pore size of no more than about 10 microns. A non-disruptive hemostasis material may comprise a thin film of material over a portion of the outside surface that is non-absorbent and thin to allow for conforming into an oral cavity, such as from a tooth extraction. A thin film may cover porous material, such as a foam, that may be elastomeric.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: January 31, 2023
    Inventors: Frank M. Chapman, Randall F. Chapman
  • Patent number: 11564887
    Abstract: The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.
    Type: Grant
    Filed: April 22, 2021
    Date of Patent: January 31, 2023
    Assignee: DSM IP ASSETS B.V.
    Inventors: Jihane Achkar, Sylvain Diguet, Bruno Leuenberger, Loni Schweikert, Olivia Vidoni
  • Patent number: 11559601
    Abstract: Hemostatic devices for promoting blood clotting can include a substrate (e.g., gauze, textile, sponge, sponge matrix, one or more fibers, etc.), a hemostatic material disposed thereon such as kaolin clay, and a binder material such as crosslinked calcium alginate with a high guluronate monomer molar percentage disposed on the substrate to substantially retain the hemostatic material material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood to accelerate clotting. Moreover, when exposed to blood, the binder has low solubility and retains a majority of the clay material on the gauze. A bandage that can be applied to a bleeding wound to promote blood clotting includes a flexible substrate and a gauze substrate mounted thereon.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: January 24, 2023
    Assignee: Teleflex Life Sciences Limited
    Inventors: Dina Dubey, Denny Lo
  • Patent number: 11554094
    Abstract: The present disclosure is directed to fatty-acid glycerol ester derivative compounds containing a targeting bisphosphonate group. The disclosure further includes pharmaceutical or biomedical compositions comprising these compounds, and methods of using these compounds and compositions forming microbubbles. The microbubbles have affinity for metal-containing, especially calcium-containing, bodies and/or biological targets. In certain embodiments, these compositions are useful for providing targeted placement of microbubbles capable of cavitation on application of high frequency energy.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: January 17, 2023
    Assignee: California Institute of Technology
    Inventors: Vanessa M. Marx, Robert H. Grubbs
  • Patent number: 11540988
    Abstract: Described herein is a wet wipe including a substrate and a lotion. The lotion includes from about 98.5% to about 99.9% water, from about 0.061% to about 0.084% benzoic acid, and from about 0.024% to about 0.072% by weight of sodium benzoate, wherein the amount of benzoic acid is greater than or equal to the amount of sodium benzoate. The benzoic acid is derived from dissociation of the sodium benzoate within the lotion. The lotion has a pH from about 3.6 to about 4.8.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: January 3, 2023
    Assignee: The Procter & Gamble Company
    Inventors: Randall Glenn Marsh, Karolin K. Kroening
  • Patent number: 11528905
    Abstract: A disposable sleeve having an antimicrobial property for covering an arm of a pair of spectacles is presently disclosed. The disposable sleeve comprises a generally tubular body having an opening at least one end thereof for receiving the spectacle arm, and at least one antimicrobial agent containing component applied to a surface of the tubular body and/or dispersed therein to impart the antimicrobial property thereto.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: December 20, 2022
    Assignee: EDYE PTY LTD
    Inventor: Donna Edye
  • Patent number: 11529292
    Abstract: Described are effervescent dissolvable solid structures having fibers formed from a composition comprising surfactant and water soluble polymeric structurant, having a total dissolvable solid structure density of from about 0.100 g/cm3to about 0.380 g/cm3, having a surfactant dose of from about 0.5 to about 2.0 g, and a surfactant density of from about 0.1 g/cm3 to about 0.3 g/cm3. Also described are processes for manufacturing the Dissolvable Solid Structure.
    Type: Grant
    Filed: June 13, 2022
    Date of Patent: December 20, 2022
    Assignee: The Procter & Gamble Company
    Inventors: Michael Sean Pratt, Jennifer Elaine Hilvert, Pamela Ann Keune, Alessandra Massa, Melanie Anne Kay, Mark William Hamersky, Mark Robert Sivik
  • Patent number: 11523989
    Abstract: A method for treating the gastro-intestinal or a urogenital system of a subject with prebiotic nutrients and probiotic bacteria is provided. Multi-chamber products are described which include at least two chambers wherein probiotic bacteria or human microbiome transplants are contained in one or more inner chambers and wherein prebiotic nutrients are contained in an outer chamber, the outer chamber completely enclosing the inner chamber(s). One or both chambers may contain a pharmaceutically acceptable material that is solid outside the human body when in a dry environment, but that melts at internal body temperature. The products may be administered by oral, rectal, vaginal, or urethral routes.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: December 13, 2022
    Inventor: Deborah L. Lynch
  • Patent number: 11498735
    Abstract: Described herein is an array of wet wipe packages displayed via a merchandise display system. The array of wet wipe packages includes a first package, a second package, and a third package. The first package includes a first wet wipe having a first coform nonwoven material and a first lotion. The second package includes a second wet wipe having a second coform nonwoven material and a second lotion. The third package includes a third wet wipe having a third coform nonwoven material and a third lotion. The third lotion is different than the first lotion and the second lotion. The first coform nonwoven material, the second coform nonwoven material, and/or the third coform nonwoven material has from about 14.5% to about 45% cotton.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: November 15, 2022
    Assignee: The Procter & Gamble Company
    Inventors: Randall Glenn Marsh, Karolin K. Kroening
  • Patent number: 11491116
    Abstract: An adhesive patch comprising: a support; at least a pressure-sensitive adhesive layer provided on the support; and a release liner attached on the pressure-sensitive adhesive layer so as to cover the surface of the pressure-sensitive adhesive layer, in which the support is a 3D patterned sheet characterized in that a plurality of protruded lines and recessed lines parallelly and linearly extending are formed inside and outside lines in a plurality of figures partitioned by the lines, walls of the protruded lines and recessed lines in some of the figures are formed to be inclined by different inclination angles with respect to a base part, and the protruded lines have different heights from the base part, serving as physical parameters of the protruded lines and recessed lines, toward a predetermined direction in the sheet.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: November 8, 2022
    Assignee: LEAD CHEMICAL CO., LTD.
    Inventors: Takayasu Matsuzawa, Seijiro Yama, Naoki Murai
  • Patent number: 11484028
    Abstract: In various embodiments, disclosed herein is a device comprising a non-planar surface, wherein nanostructures are fabricated on the non-planar surface. Also provided herein are methods of making and using a device comprising a non-planar surface, wherein nanostructures are fabricated on the non-planar surface. Further provided herein are methods of using a device comprising one or more non-planar surfaces, wherein the non-planar surfaces comprise one or more microstructures or nanostructures, comprising the steps: (a) using the device for its ordinary purpose; and (b) wherein the microstructures or nanostructures present in the device prevent proliferation of bacteria.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: November 1, 2022
    Assignee: The Regents of The University of California
    Inventors: Albert Yee, Susan Christine Wu, Mary Nora Dickson, Elena Liang
  • Patent number: 11484501
    Abstract: Particles are disclosed. Methods of making and using the particles are also disclosed.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: November 1, 2022
    Assignee: Grace GmbH
    Inventors: Hans Hermann Hoefer, Frederick Hendrik Monsuur, Thomas Pauly, Yogesh Choudhari, Korbinian Lobmann, Thomas Rades
  • Patent number: 11478424
    Abstract: Particles are disclosed. Methods of making and using the particles are also disclosed.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: October 25, 2022
    Assignee: Grace GmbH
    Inventors: Hans Hermann Hoefer, Frederik Hendrik Monsuur, Thomas Pauly, Yogesh Choudhari, Korbinian Lobmann, Thomas Rades
  • Patent number: 11452798
    Abstract: A method of treating a lesion in a gastrointestinal tract and an injectate system are provided. The method includes injecting a crosslinkable gel into a first tissue layer, the crosslinkable gel increasing a volume of the first tissue layer. The method also includes providing a crosslinker and resecting a portion of a first tissue layer having the increased volume away from a second tissue layer creating an exposed region in a remaining portion of the first layer and leaving a portion of the gel covering at least a portion of the exposed region. The injectate system includes a crosslinkable gel and a crosslinker where the crosslinkable gel and the crosslinker form a crosslinked gel having a compressive modulus of about 10-500 kPa.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: September 27, 2022
    Assignee: Cook Medical Technologies LLC
    Inventors: John C. Sigmon, Jr., Shaun D. Gittard, Gregory J. Hardy, Christopher A. Carruthers, Darin G. Schaeffer
  • Patent number: 11419759
    Abstract: A device for injecting a therapeutic agent into an ocular implant at least partially implanted in an eye including an injection lumen providing a pathway for injecting the therapeutic agent into the implant; an outlet lumen providing a pathway for pre-existing fluid in the ocular implant to exit the implant; and a collection chamber fluidly coupled to the outlet lumen that provides a first fluid outflow resistance and a second fluid outflow resistance. The first fluid outflow resistance is lower than a first resistance to outflow of the implant. The second fluid outflow resistance is greater than a force imparted onto the implant by intraocular pressure of the eye. Injection of therapeutic agent into the implant via the injection lumen causes the pre-existing fluid to exit the implant and enter the collection chamber via the outlet lumen and causes a second pre-existing fluid to displace from the collection chamber.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: August 23, 2022
    Assignee: ForSight Vision4, Inc.
    Inventors: Kevin W. Sacherman, Randolph E. Campbell, Darren Doud, Kathleen Cogan Farinas
  • Patent number: 11406740
    Abstract: In some embodiments, a method of fabricating a skin wound patch includes preparing a biopolymeric solution comprising chitosan, collagen, chondroitin sulfate, elastin, hyaluronic acid, follistatin-like 1 (FSTL-1), iron oxide nanoparticles, and AC2-26 peptide, filtering the biopolymeric solutions through a filter membrane, extruding the biopolymeric solution through an extrusion device to form a nanofibrous composite, collecting the extruded nanofibrous composite on a sterilized plate, and drying the extruded nanofibrous composite into a solid patch. In some embodiments, a skin wound patch includes homogeneously distributed biomolecules, skin materials, pro-inflammatory, and antibacterial agents. In further embodiments, a method of treating a chronic skin wound in a subject in need thereof can include applying any of the patches described herein.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: August 9, 2022
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventor: Morteza Mahmoudi
  • Patent number: 11406661
    Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain nonabsorbable compositions and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons, the conjugate base of a strong acid and/or a strong acid from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: August 9, 2022
    Assignee: TRICIDA, INC.
    Inventors: Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman